Project Grant K24DA062568
Award Date
9/30/24
Completion Date
7/31/29
Dollars Obligated
$426K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $208,575.00 to Dr. R. Kathryn McHugh at McLean Hospital to expand her mentorship of early-career investigators in patient-oriented research (POR) on substance use disorders. The award will enable Dr. McHugh to dedicate more time to mentoring current and new mentees, as well as broaden her own POR program. This includes extending existing...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,312,085 to Trustees of Boston University to conduct research on the mechanisms of persistent inflammasome activation in myeloid cells related to HIV infection and opioid use disorder. The 5-year project, starting in September 2024, will utilize human iPSC-derived microglia cultures to investigate how HIV infection and opioid exposure...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH's Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $751,043 research project at the University of Massachusetts Medical School focused on investigating the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The project will leverage single-cell sequencing technologies and other...
The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), received a $563,724 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support (CFDA 93.310) program. The project aims to provide a comprehensive, national picture of the links between substance use, firearm injuries, and reinjury in a sample of 42 million Medicaid-enrolled youth aged 13-25 across the U.S. from 2016-2020. The project seeks to...
This Project Grant award of $1,192,612 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The project will: Conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; Use an evidence-based quality improvement (EBQI) process...
This federal Project Grant award of $2,332,500.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a novel model of a prison learning health system to address disparities in HIV treatment, HIV prevention, and substance use disorder (SUD) treatment among incarcerated individuals. The key objectives of this project, which will be embedded in Washington's state prisons, are to: 1) build the foundation for a...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to increase HIV and substance use prevention and treatment among adolescent and young adult (AYA) survivors of sexual violence. The $672,206 grant, awarded on June 15, 2025, will support the following key objectives: Tailor existing Sexual Assault Nurse Examiner (SANE) services to incorporate same-day HIV prophylaxis and substance use prevention,...
The National Institute on Drug Abuse (NIDA) awarded a $264,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Innovation Research And Training, Inc. (IRT), a woman-owned small business research organization based in Durham, North Carolina. The purpose of this 3-year project, beginning September 2024, is to evaluate the "Substance of Change: Building Assets in Mentees Affected by Substance Misuse" (SOC), an interactive, multimedia, web-based,...
This $181,040 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to create an immersive training experience to study the genetic etiology of substance use disorders (SUDs). The award recipient, Yale University, will leverage the Million Veteran Program (MVP) biobank to: (1) model patterns of SUD co-occurrence and substance co-use, (2) utilize electronic health record data and toxicology results to provide...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $687,416 to the J. David Gladstone Institutes to develop therapeutically effective latency-promoting agents (LPAs) that can "block" HIV reactivation and "lock" HIV in a silenced state, even in the presence of addictive substances. The key objectives are to: 1) determine the mechanisms by which CDK9 inhibition and PP2A...